GAPDH as a sensor of NO stress

Biochimica et Biophysica Acta - Molecular Basis of Disease

Volumn 1762, Issue 5, 2006, Pages 502-509

  Hara, Makoto R ^a   Cascio, Matthew B ^a   Sawa, Akira ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Apoptosis; GAPDH; Nitric oxide; Nuclear translocation; Oxidative stress; Siah1

Indexed keywords

10 (N METHYL N PROPARGYLAMINOMETHYL)DIBENZO[B,F]OXEPIN; CYSTEINE; DIBENZ[B,F]OXEPIN 10 YLDIMETHYLTHYLPROP 2 YNYLAMINE; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; HUNTINGTIN; INDUCIBLE NITRIC OXIDE SYNTHASE; MONOAMINE OXIDASE B INHIBITOR; NEURONAL NITRIC OXIDE SYNTHASE; NEUROPROTECTIVE AGENT; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; NITRIC OXIDE; PROTEIN P53; PROTEIN SIAH1; SELEGILINE; TCH 346; UBIQUITIN PROTEIN LIGASE E3; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; APOPTOSIS; CATALYSIS; CELL DEATH; CELL NUCLEUS; CYTOTOXICITY; DEGENERATIVE DISEASE; DRUG PROTEIN BINDING; ENZYME MODIFICATION; HUMAN; HUNTINGTON CHOREA; MOLECULAR BIOLOGY; NEUROPROTECTION; NITROSYLATION; NONHUMAN; NUCLEAR LOCALIZATION SIGNAL; NUCLEOCYTOPLASMIC TRANSPORT; OXIDATIVE STRESS; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN STABILITY; PROTEIN TRANSPORT; REVIEW; SENILE PLAQUE;

ACTIVE TRANSPORT, CELL NUCLEUS; ANIMALS; APOPTOSIS; GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASES; HUMANS; NERVE DEGENERATION; NITRIC OXIDE; NUCLEAR PROTEINS;

EID: 33646103670     PISSN: 09254439     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbadis.2006.01.012     Document Type: Review

References (84)

1. Sirover M.A. New insights into an old protein: the functional diversity of mammalian glyceraldehyde-3-phosphate dehydrogenase. Biochim. Biophys. Acta 1432 (1999) 159-184
2. Chuang D.M., Hough C., and Senatorov V.V. Glyceraldehyde-3-phosphate dehydrogenase, apoptosis, and neurodegenerative diseases. Annu. Rev. Pharmacol. Toxicol. 45 (2005) 269-290
3. Huitorel P., and Pantaloni D. Bundling of microtubules by glyceraldehyde-3-phosphate dehydrogenase and its modulation by ATP. Eur. J. Biochem. 150 (1985) 265-269
4. Volker K.W., and Knull H. A glycolytic enzyme binding domain on tubulin. Arch. Biochem. Biophys. 338 (1997) 237-243
5. Kumagai H., and Sakai H. A porcine brain protein (35 K protein) which bundles microtubules and its identification as glyceraldehyde 3-phosphate dehydrogenase. J. Biochem. (Tokyo) 93 (1983) 1259-1269
6. Morero R.D., Vinals A.L., Bloj B., and Farias R.N. Fusion of phospholipid vesicles induced by muscle glyceraldehyde-3-phosphate dehydrogenase in the absence of calcium. Biochemistry 24 (1985) 1904-1909
7. Glaser P.E., and Gross R.W. Rapid plasmenylethanolamine-selective fusion of membrane bilayers catalyzed by an isoform of glyceraldehyde-3-phosphate dehydrogenase: discrimination between glycolytic and fusogenic roles of individual isoforms. Biochemistry 34 (1995) 12193-12203
8. Glaser P.E., Han X., and Gross R.W. Tubulin is the endogenous inhibitor of the glyceraldehyde 3-phosphate dehydrogenase isoform that catalyzes membrane fusion: implications for the coordinated regulation of glycolysis and membrane fusion. Proc. Natl. Acad. Sci. U. S. A. 99 (2002) 14104-14109
9. Robbins A.R., Ward R.D., and Oliver C. A mutation in glyceraldehyde 3-phosphate dehydrogenase alters endocytosis in CHO cells. J. Cell Biol. 130 (1995) 1093-1104
10. Tisdale E.J. Glyceraldehyde-3-phosphate dehydrogenase is phosphorylated by protein kinase Ciota /lambda and plays a role in microtubule dynamics in the early secretory pathway. J. Biol. Chem. 277 (2002) 3334-3341
11. Patterson R.L., van Rossum D.B., Kaplin A.I., Barrow R.K., and Snyder S.H. Inositol 1,4,5-trisphosphate receptor/GAPDH complex augments Ca2+ release via locally derived NADH. Proc. Natl. Acad. Sci. U. S. A. 102 (2005) 1357-1359
12. Morgenegg G., Winkler G.C., Hubscher U., Heizmann C.W., Mous J., and Kuenzle C.C. Glyceraldehyde-3-phosphate dehydrogenase is a nonhistone protein and a possible activator of transcription in neurons. J. Neurochem. 47 (1986) 54-62
13. Singh R., and Green M.R. Sequence-specific binding of transfer RNA by glyceraldehyde-3-phosphate dehydrogenase. Science 259 (1993) 365-368
14. Meyer-Siegler K., Mauro D.J., Seal G., Wurzer J., deRiel J.K., and Sirover M.A. A human nuclear uracil DNA glycosylase is the 37-kDa subunit of glyceraldehyde-3-phosphate dehydrogenase. Proc. Natl. Acad. Sci. U. S. A. 88 (1991) 8460-8464
15. Zheng L., Roeder R.G., and Luo Y. S phase activation of the histone H2B promoter by OCA-S, a coactivator complex that contains GAPDH as a key component. Cell 114 (2003) 255-266
16. Mansur N.R., Meyer-Siegler K., Wurzer J.C., and Sirover M.A. Cell cycle regulation of the glyceraldehyde-3-phosphate dehydrogenase/uracil DNA glycosylase gene in normal human cells. Nucleic Acids Res. 21 (1993) 993-998
17. Sundararaj K.P., Wood R.E., Ponnusamy S., Salas A.M., Szulc Z., Bielawska A., Obeid L.M., Hannun Y.A., and Ogretmen B. Rapid shortening of telomere length in response to ceramide involves the inhibition of telomere binding activity of nuclear glyceraldehyde-3-phosphate dehydrogenase. J. Biol. Chem. 279 (2004) 6152-6162
18. Kragten E., Lalande I., Zimmermann K., Roggo S., Schindler P., Muller D., van Oostrum J., Waldmeier P., and Furst P. Glyceraldehyde-3-phosphate dehydrogenase, the putative target of the antiapoptotic compounds CGP 3466 and R-(-)-deprenyl. J. Biol. Chem. 273 (1998) 5821-5828
19. Carlile G.W., Chalmers-Redman R.M., Tatton N.A., Pong A., Borden K.E., and Tatton W.G. Reduced apoptosis after nerve growth factor and serum withdrawal: conversion of tetrameric glyceraldehyde-3-phosphate dehydrogenase to a dimer. Mol. Pharmacol. 57 (2000) 2-12
20. Saunders P.A., Chalecka-Franaszek E., and Chuang D.M. Subcellular distribution of glyceraldehyde-3-phosphate dehydrogenase in cerebellar granule cells undergoing cytosine arabinoside-induced apoptosis. J. Neurochem. 69 (1997) 1820-1828
21. Chen R.W., Saunders P.A., Wei H., Li Z., Seth P., and Chuang D.M. Involvement of glyceraldehyde-3-phosphate dehydrogenase (GAPDH) and p53 in neuronal apoptosis: evidence that GAPDH is upregulated by p53. J. Neurosci. 19 (1999) 9654-9662
22. Ishitani R., and Chuang D.M. Glyceraldehyde-3-phosphate dehydrogenase antisense oligodeoxynucleotides protect against cytosine arabinonucleoside-induced apoptosis in cultured cerebellar neurons. Proc. Natl. Acad. Sci. U. S. A. 93 (1996) 9937-9941
23. Sawa A., Khan A.A., Hester L.D., and Snyder S.H. Glyceraldehyde-3-phosphate dehydrogenase: nuclear translocation participates in neuronal and nonneuronal cell death. Proc. Natl. Acad. Sci. U. S. A. 94 (1997) 11669-11674
24. Ishitani R., Tanaka M., Sunaga K., Katsube N., and Chuang D.M. Nuclear localization of overexpressed glyceraldehyde-3-phosphate dehydrogenase in cultured cerebellar neurons undergoing apoptosis. Mol. Pharmacol. 53 (1998) 701-707
25. Saunders P.A., Chen R.W., and Chuang D.M. Nuclear translocation of glyceraldehyde-3-phosphate dehydrogenase isoforms during neuronal apoptosis. J. Neurochem. 72 (1999) 925-932
26. Epner D.E., Sawa A., and Isaacs J.T. Glyceraldehyde-3-phosphate dehydrogenase expression during apoptosis and proliferation of rat ventral prostate. Biol. Reprod. 61 (1999) 687-691
27. Fukuhara Y., Takeshima T., Kashiwaya Y., Shimoda K., Ishitani R., and Nakashima K. GAPDH knockdown rescues mesencephalic dopaminergic neurons from MPP+-induced apoptosis. NeuroReport 12 (2001) 2049-2052
28. Sharma S.K., Carlson E.C., and Ebadi M. Neuroprotective actions of Selegiline in inhibiting 1-methyl, 4-phenyl, pyridinium ion (MPP+)-induced apoptosis in SK-N-SH neurons. J. Neurocytol. 32 (2003) 329-343
29. Maruyama W., Akao Y., Youdim M.B., Davis B.A., and Naoi M. Transfection-enforced Bcl-2 overexpression and an anti-Parkinson drug, rasagiline, prevent nuclear accumulation of glyceraldehyde-3-phosphate dehydrogenase induced by an endogenous dopaminergic neurotoxin, N-methyl(R)salsolinol. J. Neurochem. 78 (2001) 727-735
30. Dastoor Z., and Dreyer J.L. Potential role of nuclear translocation of glyceraldehyde-3-phosphate dehydrogenase in apoptosis and oxidative stress. J. Cell. Sci. 114 (2001) 1643-1653
31. Ishitani R., Sunaga K., Hirano A., Saunders P., Katsube N., and Chuang D.M. Evidence that glyceraldehyde-3-phosphate dehydrogenase is involved in age-induced apoptosis in mature cerebellar neurons in culture. J. Neurochem. 66 (1996) 928-935
32. Ishitani R., Kimura M., Sunaga K., Katsube N., Tanaka M., and Chuang D.M. An antisense oligodeoxynucleotide to glyceraldehyde-3-phosphate dehydrogenase blocks age-induced apoptosis of mature cerebrocortical neurons in culture. J. Pharmacol. Exp. Ther. 278 (1996) 447-454
33. Ishitani R., Sunaga K., Tanaka M., Aishita H., and Chuang D.M. Overexpression of glyceraldehyde-3-phosphate dehydrogenase is involved in low K+-induced apoptosis but not necrosis of cultured cerebellar granule cells. Mol. Pharmacol. 51 (1997) 542-550
34. Schulze H., Schuler A., Stuber D., Dobeli H., Langen H., and Huber G. Rat brain glyceraldehyde-3-phosphate dehydrogenase interacts with the recombinant cytoplasmic domain of Alzheimer's beta-amyloid precursor protein. J. Neurochem. 60 (1993) 1915-1922
35. Burke J.R., Enghild J.J., Martin M.E., Jou Y.S., Myers R.M., Roses A.D., Vance J.M., and Strittmatter W.J. Huntingtin and DRPLA proteins selectively interact with the enzyme GAPDH. Nat. Med. 2 (1996) 347-350
36. Lipton S.A., Choi Y.B., Pan Z.H., Lei S.Z., Chen H.S., Sucher N.J., Loscalzo J., Singel D.J., and Stamler J.S. A redox-based mechanism for the neuroprotective and neurodestructive effects of nitric oxide and related nitroso-compounds. Nature 364 (1993) 626-632
37. Benhar M., and Stamler J.S. A central role for S-nitrosylation in apoptosis. Nat. Cell Biol. 7 (2005) 645-646
38. Zhang J., and Snyder S.H. Nitric oxide stimulates auto-ADP-ribosylation of glyceraldehyde-3-phosphate dehydrogenase. Proc. Natl. Acad. Sci. U. S. A. 89 (1992) 9382-9385
39. Dimmeler S., Lottspeich F., and Brune B. Nitric oxide causes ADP-ribosylation and inhibition of glyceraldehyde-3-phosphate dehydrogenase. J. Biol. Chem. 267 (1992) 16771-16774
40. McDonald L.J., and Moss J. Stimulation by nitric oxide of an NAD linkage to glyceraldehyde-3-phosphate dehydrogenase. Proc. Natl. Acad. Sci. U. S. A. 90 (1993) 6238-6241
41. Mohr S., Stamler J.S., and Brune B. Posttranslational modification of glyceraldehyde-3-phosphate dehydrogenase by S-nitrosylation and subsequent NADH attachment. J. Biol. Chem. 271 (1996) 4209-4214
42. Nomura Y., Uehara T., and Nakazawa M. Neuronal apoptosis by glial NO: involvement of inhibition of glyceraldehyde-3-phosphate dehydrogenase. Hum. Cell 9 (1996) 205-214
43. Messmer U.K., and Brune B. Modification of macrophage glyceraldehyde-3-phosphate dehydrogenase in response to nitric oxide. Eur. J. Pharmacol. 302 (1996) 171-182
44. Hess D.T., Matsumoto A., Kim S.O., Marshall H.E., and Stamler J.S. Protein S-nitrosylation: purview and parameters. Nat. Rev., Mol. Cell Biol. 6 (2005) 150-166
45. Schonhoff C.M., Daou M.C., Jones S.N., Schiffer C.A., and Ross A.H. Nitric oxide-mediated inhibition of Hdm2-p53 binding. Biochemistry 41 (2002) 13570-13574
46. Matsumoto A., Comatas K.E., Liu L., and Stamler J.S. Screening for nitric oxide-dependent protein-protein interactions. Science 301 (2003) 657-661
47. Jaffrey S.R., Erdjument-Bromage H., Ferris C.D., Tempst P., and Snyder S.H. Protein S-nitrosylation: a physiological signal for neuronal nitric oxide. Nat. Cell Biol. 3 (2001) 193-197
48. Szabo C., and Dawson V.L. Role of poly(ADP-ribose) synthetase in inflammation and ischaemia-reperfusion. Trends Pharmacol. Sci. 19 (1998) 287-298
49. Pieper A.A., Verma A., Zhang J., and Snyder S.H. Poly (ADP-ribose) polymerase, nitric oxide and cell death. Trends Pharmacol. Sci. 20 (1999) 171-181
50. Ha H.C., and Snyder S.H. Poly(ADP-ribose) polymerase is a mediator of necrotic cell death by ATP depletion. Proc. Natl. Acad. Sci. U. S. A. 96 (1999) 13978-13982
51. Pieper A.A., Blackshaw S., Clements E.E., Brat D.J., Krug D.K., White A.J., Pinto-Garcia P., Favit A., Conover J.R., Snyder S.H., and Verma A. Poly(ADP-ribosyl)ation basally activated by DNA strand breaks reflects glutamate-nitric oxide neurotransmission. Proc. Natl. Acad. Sci. U. S. A. 97 (2000) 1845-1850
52. Carlile G.W., Tatton W.G., and Borden K.L. Demonstration of a RNA-dependent nuclear interaction between the promyelocytic leukaemia protein and glyceraldehyde-3-phosphate dehydrogenase. Biochem. J. 335 Pt. 3 (1998) 691-696
53. Schmitz H.D. Reversible nuclear translocation of glyceraldehyde-3-phosphate dehydrogenase upon serum depletion. Eur. J. Cell Biol. 80 (2001) 419-427
54. Brown V.M., Krynetski E.Y., Krynetskaia N.F., Grieger D., Mukatira S.T., Murti K.G., Slaughter C.A., Park H.W., and Evans W.E. A novel CRM1-mediated nuclear export signal governs nuclear accumulation of glyceraldehyde-3-phosphate dehydrogenase following genotoxic stress. J. Biol. Chem. 279 (2004) 5984-5992
55. Schmitz H.D., Dutine C., and Bereiter-Hahn J. Exportin 1-independent nuclear export of GAPDH. Cell Biol. Int. 27 (2003) 511-517
56. Hara M.R., Agrawal N., Kim S.F., Cascio M.B., Fujimuro M., Ozeki Y., Takahashi M., Cheah J.H., Tankou S.K., Hester L.D., Ferris C.D., Hayward S.D., Snyder S.H., and Sawa A. S-nitrosylated GAPDH initiates apoptotic cell death by nuclear translocation following Siah1 binding. Nat. Cell Biol. 7 (2005) 665-674
57. Li Y., Nowotny P., Holmans P., Smemo S., Kauwe J.S., Hinrichs A.L., Tacey K., Doil L., van Luchene R., Garcia V., Rowland C., Schrodi S., Leong D., Gogic G., Chan J., Cravchik A., Ross D., Lau K., Kwok S., Chang S.Y., Catanese J., Sninsky J., White T.J., Hardy J., Powell J., Lovestone S., Morris J.C., Thal L., Owen M., Williams J., Goate A., and Grupe A. Association of late-onset Alzheimer's disease with genetic variation in multiple members of the GAPD gene family. Proc. Natl. Acad. Sci. U. S. A. 101 (2004) 15688-15693
58. Welch J.E., Brown P.L., O'Brien D.A., Magyar P.L., Bunch D.O., Mori C., and Eddy E.M. Human glyceraldehyde 3-phosphate dehydrogenase-2 gene is expressed specifically in spermatogenic cells. J. Androl. 21 (2000) 328-338
59. Dawson V.L., Dawson T.M., London E.D., Bredt D.S., and Snyder S.H. Nitric oxide mediates glutamate neurotoxicity in primary cortical cultures. Proc. Natl. Acad. Sci. U. S. A. 88 (1991) 6368-6371
60. Marin-Teva J.L., Dusart I., Colin C., Gervais A., van Rooijen N., and Mallat M. Microglia promote the death of developing Purkinje cells. Neuron 41 (2004) 535-547
61. Liberatore G.T., Jackson-Lewis V., Vukosavic S., Mandir A.S., Vila M., McAuliffe W.G., Dawson V.L., Dawson T.M., and Przedborski S. Inducible nitric oxide synthase stimulates dopaminergic neurodegeneration in the MPTP model of Parkinson disease. Nat. Med. 5 (1999) 1403-1409
62. Zhang Y., Dawson V.L., and Dawson T.M. Oxidative stress and genetics in the pathogenesis of Parkinson's disease. Neurobiol. Dis. 7 (2000) 240-250
63. Vogelstein B., and Kinzler K.W. Cancer genes and the pathways they control. Nat. Med. 10 (2004) 789-799
64. Bae B.I., Xu H., Igarashi S., Fujimuro M., Agrawal N., Taya Y., Hayward S.D., Moran T.H., Montell C., Ross C.A., Snyder S.H., and Sawa A. p53 mediates cellular dysfunction and behavioral abnormalities in Huntington's disease. Neuron 47 (2005) 29-41
65. Fiucci G., Beaucourt S., Duflaut D., Lespagnol A., Stumptner-Cuvelette P., Geant A., Buchwalter G., Tuynder M., Susini L., Lassalle J.M., Wasylyk C., Wasylyk B., Oren M., Amson R., and Telerman A. Siah-1b is a direct transcriptional target of p53: Identification of the functional p53 responsive element in the siah-1b promoter. Proc. Natl. Acad. Sci. U. S. A. 101 (2004) 3510-3515
66. Foster M.W., McMahon T.J., and Stamler J.S. S-nitrosylation in health and disease. Trends Mol. Med. 9 (2003) 160-168
67. Sunaga K., Takahashi H., Chuang D.M., and Ishitani R. Glyceraldehyde-3-phosphate dehydrogenase is over-expressed during apoptotic death of neuronal cultures and is recognized by a monoclonal antibody against amyloid plaques from Alzheimer's brain. Neurosci. Lett. 200 (1995) 133-136
68. Cumming R.C., and Schubert D. Amyloid-beta induces disulfide bonding and aggregation of GAPDH in Alzheimer's disease. FASEB J. 19 (2005) 2060-2062
69. Tanaka R., Mochizuki H., Suzuki A., Katsube N., Ishitani R., Mizuno Y., and Urabe T. Induction of glyceraldehyde-3-phosphate dehydrogenase (GAPDH) expression in rat brain after focal ischemia/reperfusion. J. Cereb. Blood Flow Metab. 22 (2002) 280-288
70. Tatton N.A. Increased caspase 3 and Bax immunoreactivity accompany nuclear GAPDH translocation and neuronal apoptosis in Parkinson's disease. Exp. Neurol. 166 (2000) 29-43
71. Koshy B., Matilla T., Burright E.N., Merry D.E., Fischbeck K.H., Orr H.T., and Zoghbi H.Y. Spinocerebellar ataxia type-1 and spinobulbar muscular atrophy gene products interact with glyceraldehyde-3-phosphate dehydrogenase. Hum. Mol. Genet. 5 (1996) 1311-1318
72. Cooper A.J., Sheu K.R., Burke J.R., Onodera O., Strittmatter W.J., Roses A.D., and Blass J.P. Transglutaminase-catalyzed inactivation of glyceraldehyde 3-phosphate dehydrogenase and alpha-ketoglutarate dehydrogenase complex by polyglutamine domains of pathological length. Proc. Natl. Acad. Sci. U. S. A. 94 (1997) 12604-12609
73. Mazzola J.L., and Sirover M.A. Alteration of nuclear glyceraldehyde-3-phosphate dehydrogenase structure in Huntington's disease fibroblasts. Brain Res. Mol. Brain Res. 100 (2002) 95-101
74. Senatorov V.V., Charles V., Reddy P.H., Tagle D.A., and Chuang D.M. Overexpression and nuclear accumulation of glyceraldehyde-3-phosphate dehydrogenase in a transgenic mouse model of Huntington's disease. Mol. Cell. Neurosci. 22 (2003) 285-297
75. Browne S.E., Bowling A.C., MacGarvey U., Baik M.J., Berger S.C., Muqit M.M., Bird E.D., and Beal M.F. Oxidative damage and metabolic dysfunction in Huntington's disease: selective vulnerability of the basal ganglia. Ann. Neurol. 41 (1997) 646-653
76. Kish S.J., Lopes-Cendes I., Guttman M., Furukawa Y., Pandolfo M., Rouleau G.A., Ross B.M., Nance M., Schut L., Ang L., and DiStefano L. Brain glyceraldehyde-3-phosphate dehydrogenase activity in human trinucleotide repeat disorders. Arch. Neurol. 55 (1998) 1299-1304
77. Soucek T., Cumming R., Dargusch R., Maher P., and Schubert D. The regulation of glucose metabolism by HIF-1 mediates a neuroprotective response to amyloid beta peptide. Neuron 39 (2003) 43-56
78. Andringa G., van Oosten R.V., Unger W., Hafmans T.G., Veening J., Stoof J.C., and Cools A.R. Systemic administration of the propargylamine CGP 3466B prevents behavioural and morphological deficits in rats with 6-hydroxydopamine-induced lesions in the substantia nigra. Eur. J. Neurosci. 12 (2000) 3033-3043
79. Sagot Y., Toni N., Perrelet D., Lurot S., King B., Rixner H., Mattenberger L., Waldmeier P.C., and Kato A.C. An orally active anti-apoptotic molecule (CGP 3466B) preserves mitochondria and enhances survival in an animal model of motoneuron disease. Br. J. Pharmacol. 131 (2000) 721-728
80. Tatton W., Chalmers-Redman R., and Tatton N. Neuroprotection by deprenyl and other propargylamines: glyceraldehyde-3-phosphate dehydrogenase rather than monoamine oxidase B. J. Neural Transm. 110 (2003) 509-515
81. Waldmeier P.C., Boulton A.A., Cools A.R., Kato A.C., and Tatton W.G. Neurorescuing effects of the GAPDH ligand CGP 3466B. J. Neural Transm., Suppl. (2000) 197-214
82. Simon L., Szilagyi G., Bori Z., Orbay P., and Nagy Z. (-)-d-Deprenyl attenuates apoptosis in experimental brain ischaemia. Eur. J. Pharmacol. 430 (2001) 235-241
83. House C.M., Frew I.J., Huang H.L., Wiche G., Traficante N., Nice E., Catimel B., and Bowtell D.D. A binding motif for Siah ubiquitin ligase. Proc. Natl. Acad. Sci. U. S. A. 100 (2003) 3101-3106
84. Hara M.R., Thomas B., Cascio M.B., Bae B.-Il., Hester L.D., Dawson V.L., Dawson T.M., Sawa A., and Snyder S.H. Neuroprotection by pharmacologic blockade of the GAPDH death cascade. Proc. Natl. Acad. Sci. U. S. A. 103 (2006) 3887-3889